Annie Apffel

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Dna Methylation

Inflammatory Response

Top Venues

Nature biotechnology

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Eva J Schaefer, Helen C Wang, Hannah Q Karp, Clifford A Meyer, Paloma Cejas, Micah D Gearhart, Emmalee R Adelman, Iman Fares, Annie Apffel, Klothilda Lim, Yingtian Xie, Christopher J Gibson, Monica Schenone, H Moses Murdock, Eunice S Wang, Lukasz P Gondek, Martin P Carroll, Rahul S Vedula, Eric S Winer, Jacqueline S Garcia, Richard M Stone, Marlise R Luskin, Steven A Carr, Henry W Long, Vivian J Bardwell, Maria E Figueroa, R Coleman Lindsley
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes. Blood cancer discovery 3 (2) (2022)
Tamara Ouspenskaia, Travis Law, Karl R Clauser, Susan Klaeger, Siranush Sarkizova, François Aguet, Bo Li, Elena Christian, Binyamin Asher Knisbacher, Phuong M Le, Christina R Hartigan, Hasmik Keshishian, Annie Apffel, Giacomo Oliveira, Wandi Zhang, Sarah Chen, Yuen Ting Chow, Zhe Ji, Irwin Jungreis, Sachet A Shukla, Sune Justesen, Pavan Bachireddy, Manolis Kellis, Gad A Getz, Nir Hacohen, Derin B Keskin, Steven A Carr, Catherine J Wu, Aviv Regev
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nature biotechnology (2021)